Posted by Michael Wonder on 30 Jan 2026
Canadians wait too long for access to innovative drugs, cautions the MEI
29 January 2026 - Pharmaceutical innovation is responsible for up to 66% of the increase in the age of death in the US, and 73% in 26 high-income countries.
Long approval delays and price control policies for new drugs harm Canadians with health problems, says an MEI researcher in an Economic Note released this morning.
